| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.091 | 0.004 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.16 | 0.004 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.088 | 0.004 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | 0.092 | 0.005 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.09 | 0.006 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.084 | 0.006 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | 0.087 | 0.006 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.006 |